Patents by Inventor Dennis Elias Saadeh

Dennis Elias Saadeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200101076
    Abstract: Pharmaceutical compositions and methods for preventing, treating, or alleviating cytokine release syndrome are described, the compositions comprising pentoxifylline and a pharmaceutically acceptable carrier. Methods for using such compositions are also described.
    Type: Application
    Filed: September 25, 2019
    Publication date: April 2, 2020
    Applicant: Harrow IP, LLC
    Inventors: Annette Marleau, Thomas Ichim, Dennis Elias Saadeh
  • Patent number: 10555952
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: February 11, 2020
    Assignee: Melt Pharmaceuticals, Inc.
    Inventors: Mark Baum, John Berdahl, William Wiley, Dennis Elias Saadeh
  • Publication number: 20190374540
    Abstract: Pharmaceutical compositions that include aqueous suspensions of a therapeutically effective quantity of a diaminopyrimidine compound (such as pyrimethamine) are provided herein. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: June 6, 2019
    Publication date: December 12, 2019
    Inventors: Dennis Elias Saadeh, Annette Marleau, Thomas Ichim
  • Patent number: 10426744
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing fungal nail diseases, disorders or pathologies are described, the compositions comprising at least one functionalized allylamine compound, at least one functionalized triazole compound, and at least one functionalized imidazole compound. Methods for fabricating the compositions and using them are also described.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: October 1, 2019
    Assignee: Harrow Health, Inc.
    Inventor: Dennis Elias Saadeh
  • Patent number: 10391102
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: August 27, 2019
    Assignee: Melt Pharmaceuticals, Inc.
    Inventors: John Berdahl, William F. Wiley, Dennis Elias Saadeh
  • Publication number: 20190151338
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing inflammatory skin diseases, disorders and/or pathologies are described, the compositions comprising a tetracycline-class antibiotic(s), omega fatty acid(s), and/or nicotinic acid or derivatives thereof. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: January 24, 2019
    Publication date: May 23, 2019
    Inventor: Dennis Elias Saadeh
  • Publication number: 20190142841
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, an NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Compositions may be incorporated into vehicles for extended release. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: January 17, 2019
    Publication date: May 16, 2019
    Inventor: Dennis Elias Saadeh
  • Publication number: 20190134163
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: January 17, 2019
    Publication date: May 9, 2019
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Publication number: 20190111045
    Abstract: Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial agent (such as moxifloxacin), a therapeutically effective quantity of an anti-inflammatory agent (such as prednisolone), a combination of at least two solubilizing and suspending agents (of which one is a non-ionic polyoxyethlene-polyoxypropylene block copolymer), and a carrier. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: May 3, 2017
    Publication date: April 18, 2019
    Inventors: William Wiley, Richard Dilzer, Dennis Elias Saadeh, Jeffrey T. Liegner, John Scott Karolchyk, Bernard Covalesky, Kallan Peters
  • Publication number: 20190060266
    Abstract: Pharmaceutical compositions are described herein, the compositions consisting essentially of anhydrous suspensions of therapeutically effective quantity of a pharmaceutically acceptable reducing agent capable of undergoing thiol-disulfide exchange with cystine to form a mixed disulfide (such as tiopronin). In some embodiments, the suspension also contains one or more urine alkanizing agent(s). Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: October 30, 2018
    Publication date: February 28, 2019
    Inventor: Dennis Elias Saadeh
  • Patent number: 10179136
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: January 15, 2019
    Assignee: Imprimis Pharmaceuticals, Inc.
    Inventors: John Berdahl, William F. Wiley, Dennis Elias Saadeh
  • Patent number: 10166240
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: January 1, 2019
    Assignee: Imprimis Pharmaceuticals, Inc.
    Inventors: John Berdahl, William F. Wiley, Dennis Elias Saadeh
  • Publication number: 20180311188
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing fungal nail diseases, disorders or pathologies are described, the compositions comprising at least one functionalized allylamine compound, at least one functionalized triazole compound, and at least one functionalized imidazole compound. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: July 3, 2018
    Publication date: November 1, 2018
    Inventor: Dennis Elias Saadeh
  • Publication number: 20180303847
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: June 28, 2018
    Publication date: October 25, 2018
    Inventors: Mark Baum, John Berdahl, William Wiley, Dennis Elias Saadeh
  • Publication number: 20180271877
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: June 1, 2018
    Publication date: September 27, 2018
    Inventors: John Berdahl, William F. Wiley, Dennis Elias Saadeh
  • Publication number: 20180177796
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: February 23, 2018
    Publication date: June 28, 2018
    Inventors: John Berdahl, William F. Wiley, Dennis Elias Saadeh
  • Publication number: 20180177797
    Abstract: Pharmaceutical compositions and methods for inducing conscious sedation using such compositions are described, the compositions including a benzodiazepine-based compound, a NMDA antagonist, and optionally a ?-blocker, antiemetic, an NSAID, and/or an antihistamine medication. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Application
    Filed: February 23, 2018
    Publication date: June 28, 2018
    Inventors: John Berdahl, William F. Wiley, Dennis Elias Saadeh
  • Publication number: 20180169191
    Abstract: Pharmaceutical compositions for treating, mitigating or preventing multiple sclerosis, autoimmune diseases and associated conditions are described herein. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: June 13, 2017
    Publication date: June 21, 2018
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Publication number: 20180169092
    Abstract: Pharmaceutical compositions for treating or mitigating glaucoma are described, the compositions comprising several separate components for an improved effect. Methods for fabricating the compositions and using them are also described.
    Type: Application
    Filed: December 5, 2017
    Publication date: June 21, 2018
    Inventors: Dennis Elias Saadeh, Mark L. Baum
  • Patent number: 9918993
    Abstract: Pharmaceutical compositions and methods are described, the compositions comprising a benzodiazepine-based compound, a NMDA antagonist, a ?-blocker and antiemetic. Methods for fabricating the compositions and using them for anesthesiological applications are also described.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: March 20, 2018
    Assignee: IMPRIMIS PHARMACEUTICALS, INC.
    Inventors: John Berdahl, William F. Wiley, Dennis Elias Saadeh